Related Experiment Videos
Pharmacokinetics of kanamycin in the developing rat
C M Henley1, R A Weatherly, C N Ou
1Bobby R. Alford Department of Otorhinolaryngology and Communicative Sciences, Baylor College of Medicine, Houston, TX 77030, USA. chenley@bcm.tmc.edu
Hearing Research
|September 15, 1996
Summary
Young rats are highly sensitive to kanamycin ototoxicity due to prolonged drug exposure during critical cochlear development. This hypersensitivity is linked to longer kanamycin elimination half-life in immature mammals.
Area of Science:
- Ototoxicology
- Developmental Biology
- Pharmacokinetics
Background:
- Aminoglycoside ototoxicity poses a significant risk, particularly during sensitive developmental periods.
- Developing rats exhibit heightened susceptibility to kanamycin-induced ototoxicity between postnatal days 11-20.
Purpose of the Study:
- To investigate the pharmacokinetic basis for kanamycin hypersensitivity in developing rats.
- To correlate kanamycin serum levels and elimination half-life with ototoxicity during critical developmental windows.
Main Methods:
- Characterization of kanamycin serum pharmacokinetics in 12-day-old and 25-day-old rats.
- Comparison of kanamycin elimination half-life between immature and mature rats.
Main Results:
- Kanamycin treatment during postnatal days 11-20 induced ototoxicity in rats.
- Kanamycin administration after postnatal day 20 did not result in ototoxicity unless treatment was prolonged (> or = 20 days).
- A >2.5-fold longer elimination half-life of kanamycin was observed in 12-day-old rats compared to 25-day-old rats.
Conclusions:
- The prolonged elimination half-life of kanamycin in immature rats contributes to their hypersensitivity to aminoglycoside ototoxicity.
- Developmental stage significantly influences the risk and manifestation of kanamycin-induced ototoxicity.